Predictive Oncology Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingGlobeNewsWire • Wednesday
Predictive Oncology Reports Year End 2023 Financial Results and Provides Business UpdateGlobeNewsWire • 03/28/24
Predictive Oncology Reports Third Quarter 2023 Financial Results and Provides Business UpdateGlobeNewsWire • 11/14/23
Predictive Oncology completes AI-driven cancer study with UPMC Magee-Womens HospitalProactive Investors • 11/08/23
Predictive Oncology Completes AI-driven Study of Ovarian Cancer with UPMC Magee-Womens HospitalGlobeNewsWire • 11/08/23
Predictive Oncology dramatically narrows its quarterly loss in latest financial resultsProactive Investors • 08/10/23
Predictive Oncology Reports Second Quarter 2023 Financial Results and Provides Business UpdateGlobeNewsWire • 08/10/23
Predictive Oncology to Report Second Quarter 2023 Financial Results and Host Conference Call and Webcast on Thursday, August 10, 2023GlobeNewsWire • 08/03/23
Predictive Oncology Announces Relocation of Corporate Headquarters to PittsburghGlobeNewsWire • 07/18/23
Predictive Oncology adds biopharmaceutical CFO Andrew Einhorn to business advisory boardProactive Investors • 06/27/23
Predictive Oncology Appoints Biopharmaceutical Finance Veteran Mr. Andrew Einhorn to its Business Advisory BoardGlobeNewsWire • 06/27/23